Or click and collect!
Or click and collect!
Lung capacity is a key measure of respiratory fitness and long-term health. Here is what the current evidence shows about vaping's effects on lung function measurements, how they compare to smoking and what ex-smokers can expect after switching.
Current research on vaping and lung function shows modest effects compared to non-vapers — slightly reduced airflow measurements in some studies, increased airway inflammation markers — but these effects are substantially smaller than the lung capacity damage caused by tobacco smoking. Former smokers who switch to vaping typically see significant improvements in spirometry measurements within weeks to months as the combustion-specific damage to their airways begins to resolve. The honest assessment is that regular vapour inhalation is not completely without lung function implications, but it is dramatically less damaging to lung capacity than cigarette smoking.
Lung function is most commonly assessed through spirometry, which measures forced expiratory volume in one second (FEV1 — how much air you can blow out in a single second of maximum effort) and forced vital capacity (FVC — the total volume of air you can exhale after a maximum inhalation). The ratio of FEV1 to FVC indicates whether any obstruction to airflow is present. Healthy adults without respiratory disease have FEV1/FVC ratios above 70%. Obstructive lung disease — such as COPD from smoking — reduces this ratio progressively.
Studies comparing vapers with non-vapers have found mixed results. Some studies show slightly reduced FEV1 and increased airway resistance in long-term vapers compared to non-vaping non-smokers. Others show no significant difference. The inconsistency partly reflects the relatively short history of vaping and the difficulty of controlling for prior smoking history in study populations. A 2021 American Journal of Respiratory and Critical Care Medicine study found that daily vaping was associated with increased respiratory symptoms but more modest spirometric changes than smoking. The overall picture is that vaping's lung function impact, while real, is substantially smaller than smoking's.
Tobacco smoking causes progressive, irreversible destruction of lung tissue through several mechanisms: tar accumulation impairs alveolar function, combustion carcinogens cause epithelial damage, and the inflammatory response to smoke produces chronic obstructive changes. Long-term smokers show marked reductions in FEV1 and FVC, with COPD — a major cause of disability and death — developing in a significant proportion of long-term heavy smokers. None of the specific combustion mechanisms apply to vaping. The lung capacity comparison between vaping and smoking is dramatically in vaping's favour.
Former smokers who switch to vaping typically show measurable improvements in lung function within one to three months. FEV1 and FVC measurements improve as the airways recover from the absence of combustion products — tar is no longer being deposited, carbon monoxide is no longer impairing oxygen exchange, and the inflammatory load from combustion carcinogens diminishes. The rate of improvement is greatest in the first three months and continues more gradually thereafter. Structural damage already done — emphysema, for example — does not reverse, but the rate of ongoing functional decline stops and reverses direction.
"When customers who have switched from smoking come back a few months later they often comment on their breathing. Better exercise tolerance, less morning mucus. That is the lung recovery beginning."
Touch of Vape team, CoventryUK TRPR-regulated e-liquids cannot contain diacetyl or other banned compounds associated with airway damage. Buying from a regulated retailer gives meaningful protection that unregulated imports do not.
Any new or worsening breathlessness, wheeze, persistent cough or chest tightness warrants a GP visit regardless of vaping status. Do not attribute new respiratory symptoms to vaping without medical assessment.
If you have switched from cigarettes to vaping, your lung capacity trajectory has almost certainly improved. The absence of combustion products removes the primary driver of progressive lung function decline in smokers.
The current evidence is cautiously positive compared to smoking but we do not yet have the multi-decade follow-up data needed to fully characterise very long-term lung capacity effects. This is the honest current position of the evidence base.
We give evidence-based answers to respiratory health questions without overstating or understating what the science shows.
To find our Coventry store, visit our Vape Shop Coventry page.
Our Health guide covers lung capacity, respiratory function and the evidence on vaping and breathing — written honestly with reference to current research.
Find more respiratory health guides in our Health guide.
Evidence-based and balanced — because you deserve answers that reflect what the science actually shows.